...
首页> 外文期刊>American Journal of PharmTech Research >Evaluation of Anti Bacterial Efficacy of Chitosan Loaded Levofloxacin Nanoparticle Prepared By Emulsion Solvent Diffusion Method
【24h】

Evaluation of Anti Bacterial Efficacy of Chitosan Loaded Levofloxacin Nanoparticle Prepared By Emulsion Solvent Diffusion Method

机译:乳胶溶剂扩散法制备的壳聚糖负载左氧氟沙星纳米颗粒的抗菌效果评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT The aim of the present study was an attempt to formulate and evaluate Levofloxacin loaded chitosan nanoparticles (CS-NP) by Emulsion solvent diffusion method using poloxamer 188 as surfactant; about eight different formulations (F1-F8) were prepared by changing the ratios of drug and excipients . Among all the formulations F3 was selected as optimized formulations  based on the physico chemical parameters and drug release studies and  it was incorporated in to 1% W/W of Carbopol gel (GF3) to obtained ophthalmic gel ,further, it was evaluated for antimicrobial activity against S. aureus and Bacillus subtilis. Compatibility studies by FT-IR showed no significant interactions between drug and excipients. The prepared Chitosan nanoparticle were characterized for different parameters like particle size analysis, zeta measurement, SEM, % drug content, entrapment efficiency, FT-IR, DSC, In-vitro release. The Gel containing chitosan nanoparticles (GF3)  were evaluated for different parameters like physical examination, pH, spread ability, viscosity, reological property, % drug content and  In-vitro release. The in vitro dug release and antimicrobial efficacy of GF3 formulation was compared with marketed product. From the results it was observed that the formulation controlled the drug release over a period of 24 hrs following Higuchi model and nonfickian diffusion mechanism with better antimicrobial action than the marketed product. The ocular irritancy study confirmed that ther is no irritation to the eye. From the above study we can conclude that the Levofloxacin loaded CS-NP were successfully prepared by emulsion solvent diffusion method and it is found to be  suitable for sustained ocular drug delivery having improved antibacterial action. Keywords: Levofloxacin, Chitosan nanoparticles (CS-NP), DSC, FT-IR and Antimicrobial studies. 
机译:摘要本研究的目的是尝试通过使用泊洛沙姆188作为表面活性剂的乳液溶剂扩散法来配制和评估载有左氧氟沙星的壳聚糖纳米颗粒(CS-NP)。通过改变药物和赋形剂的比例制备了大约八种不同的制剂(F1-F8)。根据理化参数和药物释放研究,在所有制剂中选择F3作为优化制剂,并将其掺入1%W / W的Carbopol凝胶(GF3)中以获得眼用凝胶,进一步评估其抗菌活性对抗金黄色葡萄球菌和枯草芽孢杆菌。 FT-IR的相容性研究表明,药物和赋形剂之间没有明显的相互作用。制备的壳聚糖纳米颗粒的特征在于不同的参数,例如粒度分析,ζ测量,SEM,药物含量%,包封率,FT-IR,DSC,体外释放。对含有壳聚糖纳米颗粒(GF3)的凝胶进行了不同参数的评估,例如物理检查,pH,铺展能力,粘度,生物学特性,%药物含量和体外释放。将GF3制剂的体外挖掘释放和抗菌功效与市售产品进行了比较。从结果中观察到,该制剂按照Higuchi模型和非尼克扩散机制在24小时内控制药物释放,具有比市售产品更好的抗微生物作用。眼睛刺激性研究证实,对眼睛没有刺激性。从上述研究中我们可以得出结论,通过乳液溶剂扩散法成功制备了左氧氟沙星负载的CS-NP,并且发现其具有改善的抗菌作用,适合于持续的眼药输送。关键字:左氧氟沙星,壳聚糖纳米颗粒(CS-NP),DSC,FT-IR和抗菌研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号